Cubist Systematic Strategies, LLC Editas Medicine, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 471,208 shares of EDIT stock, worth $589,010. This represents 0.01% of its overall portfolio holdings.

Number of Shares

471,208

Holding current value

$589,010

% of portfolio

0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.39 - $5.96 $1.6 Million - $2.81 Million	471,208 New	471,208 $1.61 Million
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $1.33 Million - $2.36 Million	212,170 New	212,170 $2.15 Million
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $2.32 Million - $4.18 Million	-364,591 Reduced 87.0%	54,497 $448,000
Q1 2023 May 15, 2023	BUY	$7.03 - $11.53 $2.95 Million - $4.83 Million	419,088 New	419,088 $3.04 Million
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $1.81 Million - $2.89 Million	148,984 Added 65.36%	376,927 $4.61 Million
Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $2.14 Million - $4.57 Million	214,243 Added 1563.82%	227,943 $2.7 Million
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $632,994 - $1.24 Million	-44,957 Reduced 76.64%	13,700 $261,000
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $1.39 Million - $2.12 Million	52,183 Added 806.04%	58,657 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $163,009 - $302,773	-4,151 Reduced 39.07%	6,474 $266,000
Q2 2021 Aug 16, 2021	SELL	$31.29 - $56.64 $1.91 Million - $3.46 Million	-61,010 Reduced 85.17%	10,625 $602,000
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $179,926 - $410,417	4,531 Added 6.75%	71,635 $3.01 Million
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $970,567 - $3.02 Million	35,854 Added 114.73%	67,104 $4.71 Million
Q3 2020 Nov 16, 2020	BUY	$28.06 - $37.16 $172,793 - $228,831	6,158 Added 24.54%	31,250 $877,000
Q2 2020 Aug 14, 2020	SELL	$18.5 - $34.34 $844,488 - $1.57 Million	-45,648 Reduced 64.53%	25,092 $742,000
Q1 2020 May 15, 2020	BUY	$14.88 - $32.78 $888,380 - $1.96 Million	59,703 Added 540.94%	70,740 $1.4 Million
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $215,111 - $360,137	11,037 New	11,037 $327,000
Q3 2019 Nov 14, 2019	SELL	$22.49 - $26.81 $1.09 Million - $1.3 Million	-48,326 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $989,716 - $1.34 Million	48,326 New	48,326 $1.2 Million
Q1 2019 May 15, 2019	SELL	$19.43 - $26.41 $68,626 - $93,280	-3,532 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $3,638 - $6,358	200 Added 6.0%	3,532 $80,000
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $92,129 - $127,915	3,332 New	3,332 $106,000
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $333,813 - $435,977	-10,631 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $317,229 - $468,614	10,631 New	10,631 $352,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Editas Medicine, Inc. Transaction History